These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis. Leali D; Inforzato A; Ronca R; Bianchi R; Belleri M; Coltrini D; Di Salle E; Sironi M; Norata GD; Bottazzi B; Garlanda C; Day AJ; Presta M Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):696-703. PubMed ID: 22267482 [TBL] [Abstract][Full Text] [Related]
5. Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2. Ribatti D; Gualandris A; Belleri M; Massardi L; Nico B; Rusnati M; Dell'Era P; Vacca A; Roncali L; Presta M J Pathol; 1999 Dec; 189(4):590-9. PubMed ID: 10629563 [TBL] [Abstract][Full Text] [Related]
6. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Rusnati M; Camozzi M; Moroni E; Bottazzi B; Peri G; Indraccolo S; Amadori A; Mantovani A; Presta M Blood; 2004 Jul; 104(1):92-9. PubMed ID: 15031207 [TBL] [Abstract][Full Text] [Related]
7. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. Ribatti D; Nico B; Morbidelli L; Donnini S; Ziche M; Vacca A; Roncali L; Presta M J Vasc Res; 2001; 38(4):389-97. PubMed ID: 11455210 [TBL] [Abstract][Full Text] [Related]
8. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process. Presta M; Rusnati M; Belleri M; Morbidelli L; Ziche M; Ribatti D Cancer Res; 1999 May; 59(10):2417-24. PubMed ID: 10344752 [TBL] [Abstract][Full Text] [Related]
9. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776 [TBL] [Abstract][Full Text] [Related]
10. Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2. Giuliani R; Bastaki M; Coltrini D; Presta M J Cell Sci; 1999 Aug; 112 ( Pt 15)():2597-606. PubMed ID: 10393815 [TBL] [Abstract][Full Text] [Related]
12. In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2. Ribatti D; Leali D; Vacca A; Giuliani R; Gualandris A; Roncali L; Nolli ML; Presta M J Cell Sci; 1999 Dec; 112 ( Pt 23)():4213-21. PubMed ID: 10564640 [TBL] [Abstract][Full Text] [Related]
13. Angiogenic activity of rat mast cells in the chick embryo chorioallantoic membrane is down-regulated by treatment with recombinant human alpha-2a interferon and partly mediated by fibroblast growth factor-2. Ribatti D; Crivellato E; Candussio L; Vacca A; Nico B; Benagiano V; Roncali L; Dammacco F Haematologica; 2002 May; 87(5):465-71. PubMed ID: 12010658 [TBL] [Abstract][Full Text] [Related]
14. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. Ribatti D; Gualandris A; Bastaki M; Vacca A; Iurlaro M; Roncali L; Presta M J Vasc Res; 1997; 34(6):455-63. PubMed ID: 9425998 [TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic activity of the purine analog 6-thioguanine. Presta M; Belleri M; Vacca A; Ribatti D Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690 [TBL] [Abstract][Full Text] [Related]
16. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Davis FB; Mousa SA; O'Connor L; Mohamed S; Lin HY; Cao HJ; Davis PJ Circ Res; 2004 Jun; 94(11):1500-6. PubMed ID: 15117822 [TBL] [Abstract][Full Text] [Related]
17. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells. Yeh CH; Peng HC; Yang RS; Huang TF Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719 [TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. Collin-Osdoby P; Rothe L; Bekker S; Anderson F; Huang Y; Osdoby P J Bone Miner Res; 2002 Oct; 17(10):1859-71. PubMed ID: 12369790 [TBL] [Abstract][Full Text] [Related]
19. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432 [TBL] [Abstract][Full Text] [Related]
20. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Ribatti D; Presta M; Vacca A; Ria R; Giuliani R; Dell'Era P; Nico B; Roncali L; Dammacco F Blood; 1999 Apr; 93(8):2627-36. PubMed ID: 10194442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]